To evaluate whether or not the number of endoleaks has decreased during and after the learning period and after the replacement of several "first generation" endovascular devices.
How were differences between studies investigated?
Studies were grouped according to year of publication, device configuration and device type and outcomes compared to the overall rate of endoleaks.
Results of the review
Twenty-three studies were included (1189 patients, of whom 1118 patients available for follow-up analysis).
71 (6%) of procedures were converted to laparotomy at the initial implantation. 270 (24%) of patients had an endoleak, either immediately after treatment or during follow-up.
Year of publication and endoleak rate: 1996 leak rate = 16% (25/155 grafts); 1997 and 1998 leak rate = 25% (245/ 985 grafts).
Site of endoleak: The majority of endoleaks arose from the distal stent attachment site (36%). Rates for other sites were: proximal stent attachment site 24%; side branch 18%; and graft related 15%. Timing of endoleak: most occurred immediately (66%). Delayed leak accounted for 27% and recurrent leak for 2%.
Fate of endoleak with time: most were persistent (37%). Other fates: spontaneous thrombosis 21%; radiological intervention 30%; conversion 10%.
Device configuration: tube grafts had the highest rate of endoleak (35%), significantly higher than the bifurcated graft leak rate (18%; P < 0.0001) and the mixed graft leak rate (20%; P = 0.002). Device type: leak rates in the Corvita group (52%) and the first generation EVT (44%) were higher than that of other devices (leak rates ranged from 6% to 26%). In the Stentor -Vanguard group 24% of leaks were graft related.
Self-expanding stent-grafts were significantly more frequently associated with endoleaks than balloon-expandable stent grafts (25% vs 17%; P = 0.037). The balloon-expandable graft had a higher proportion of endoleaks than the selfexpanding grafts (66% vs 34%; P = 0.001). Delayed endoleaks were more common in the balloon-expandable graft compared to the self-expanding grafts (52% vs 25%).
Authors' conclusions
Endovascular treatment of abdominal aortic aneurysm is an evolving field. Even after the initial learning curve and attention to device-related problems, it is still accompanied by a significant number of endoleaks. Uniform presentation of results of treatment is necessary for analysing the effect of differences between patients, aneurysm morphology and device type.
CRD commentary
The aims and inclusion criteria were stated. Articles in four languages were considered for inclusion and full details of the search strategy were given. However, only one database was searched. Some investigation was undertaken of factors that may influence results. As the authors mention in the discussion, the inability to analyse results taking account of patient selection, graft sizing, aortic morphology and technical difficulty during implementation, limits the conclusions that can be drawn from the data.
Limiting included studies to those located in one database may have resulted in the omission of some relevant studies. No attempt was made to locate unpublished studies thus raising the possibility of publication bias. Methods used to select primary studies and extract data were not described. Neither validity nor heterogeneity was assessed. No investigation was reported of potential confounding factors such as surgical centre and experience of operator. It is not clear what proportion of such operations were included in the review and hence how representative the results reported were of all such operations.
In view of the above, caution is advised when considering these results. The authors state that results from major endovascular registries are being presented at conferences and will be published in the near future.
